Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

MAZEMAZE
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MAZE THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 293,144 shares of MAZE (MAZE THERAPEUTICS INC), worth $8.7M as of 2026-Q2. The position was increased (+4.8% shares). MAZE represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$8.7M

Current Shares

293,144

Total Value Change

+$8.6M

Total Shares Change

+280,015

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
293,144
+4.8%
$8.7M0.0%$29.84
29
2026-Q1
Increased
279,713
+144.4%
$8.3M0.0%$44.18
44
2025-Q4
New
114,455
-
$4.7M0.0%$40.05
37
2025-Q2
Exited
0
-100.0%
$00.0%$12.13
0
2025-Q1
New
13,129
-
$144,5500.0%$11.42
34

Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used